Search Results 301-310 of 19527 for Neutrophil

  1. Hematology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  2. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    Absolute neutrophil count (ANC) < 1.0 x 10^9/L; · PLT count < 100 x 10^9/L or hemoglobin < 100 g/L (i.e., 10 g/dL) at the lowest dose of HU required to achieve a ...

  3. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  4. Neurology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  5. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  6. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    < 5% bone marrow blasts;; Absolute neutrophil count ≥ 1.0 x10^9/L;; Platelets ≥ 50 x10^9/L (transfusion permitted);; Hemoglobin level ≥ 90 ...

  7. A Study Of CIN-107 In Adults With Primary Aldosteronism - Mayo Clinic

    White blood cell count > 15 x 10⁹/L or absolute neutrophil count < 1 x 10⁹/L;; Serum potassium < 2.5 mEq/L;; Patients with a serum potassium level below ...

  8. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  9. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

    Participation eligibility · Part 1 · Absolute neutrophil count ≥ 1500/μL (≥ 1.5 × 10^9 /L) without growth factor support for 7 days (14 days if on pegfilgrastim); ...

  10. Oncology (Medical) - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...